These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17061740)

  • 21. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
    Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and coronary heart disease in Durban blacks--the missing links.
    Seedat YK; Mayet FG; Latiff GH; Joubert G
    S Afr Med J; 1992 Oct; 82(4):251-6. PubMed ID: 1411822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
    Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD
    J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ohashi Y; Akanuma Y; Yamada N;
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3448-56. PubMed ID: 21865372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
    Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
    Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study.
    Imke C; Rodriguez BL; Grove JS; McNamara JR; Waslien C; Katz AR; Willcox B; Yano K; Curb JD
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1718-22. PubMed ID: 15947240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study.
    Robins SJ; Lyass A; Zachariah JP; Massaro JM; Vasan RS
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1208-14. PubMed ID: 21311041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).
    Chandra A; Neeland IJ; Das SR; Khera A; Turer AT; Ayers CR; McGuire DK; Rohatgi A
    Am J Cardiol; 2015 Apr; 115(7):890-4. PubMed ID: 25661572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly.
    Mazza A; Tikhonoff V; Schiavon L; Casiglia E
    Intern Med J; 2005 Oct; 35(10):604-10. PubMed ID: 16207260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
    Laakso M; Lehto S; Penttilä I; Pyörälä K
    Circulation; 1993 Oct; 88(4 Pt 1):1421-30. PubMed ID: 8403288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
    Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND
    Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.